- Syndecan-2 Methylation as a New Biomarker for Early Detection of Colorectal Neoplasm
-
Kim JH, Park SC
- KMID: 2424074
- Gut Liver.
- 2018 Sep;12(5):479-480.
- doi: 10.5009/gnl18286
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Immunohistochemical Study for the Syndecan-2 in Cutaneous Melanoma and Pigmented Nevus
-
Yoon WJ, Choi SR, Noh TK, Park HY, Choi JR, Chang SE, Lee MW, Choi JH
- KMID: 1864403
- Korean J Dermatol.
- 2013 Oct;51(10):776-781.
BACKGROUND: Melanoma is a malignant neoplasm originating from melanocytes. It has been recently suggested that syndecan-2 may contribute to the aggressive phenotype and metastatic potential of melanoma in cell line... -
- CITED
-
- Close
- SHARE
-
- Close
- Analysis of Syndecan-2 Methylation in Bowel Lavage Fluid for the Detection of Colorectal Neoplasm
-
Park YS, Kim DS, Cho SW, Park JW, Jeon SJ, Moon TJ, Kim SH, Son BK, Oh TJ, An S, Kim JH, Chae JD
- KMID: 2424078
- Gut Liver.
- 2018 Sep;12(5):508-515.
- doi: 10.5009/gnl17357
BACKGROUND/AIMS: Syndecan-2 (SDC2) methylation was previously reported as a sensitive serologic biomarker for the early detection of colorectal cancer (CRC). The purpose of this study was to investigate whether SDC2... -
- CITED
-
- Close
- SHARE
-
- Close
